Skip to main content

Table 1 Summary schedule of investigations: (* = completed as part of standard care). Patients will be asked to self-report their weight, physical activity levels and complete the PAM at 12-weeks. This interim “visit” will be conducted by telephone

From: Feasibility and acceptability of an evidence-informed digital intervention to support self-management in people with non-alcoholic fatty liver disease: protocol for a non-randomised feasibility study (VITALISE)

Visit

1

2 (Virtual)

3

Timescale

0

12-weeks

6-months

Study Procedure

Review inclusion/exclusion

X

  

Obtain informed consent

X

  

Height*

X

  

Weight*

X

X

X

Waist and hip circumference*

X

 

X

Blood pressure*

X

 

X

Fibroscan* (LSM1, IQR/med ratio2, CAP3 and CAP IQR4)

X

 

X

Bloods: Glucose*, Lipid profile*, LBTs5*, FBC6*, HbA1c7*

X

 

X

Calculation of: QRISK38*, FIB-49*, NFS10*

X

 

X

Physical activity: Step count

Accelerometry (7-days)

X

X

X

X

X

Questionnaires: PAM Score11, Godin Physical Activity

X

X

X

Semi-structured interview

  

X

  1. 1Liver stiffness measurement
  2. 2Interquartile range/median ratio
  3. 3Controlled attenuation parameter
  4. 4Controlled attenuation parameter interquartile range
  5. 5Liver blood tests
  6. 6Full blood count
  7. 7Glycated haemoglobin
  8. 8Cardiovascular disease risk score
  9. 9Fibrosis-4 Score
  10. 10NAFLD Fibrosis Score
  11. 11Patient Activation Measure